Simplex Trading’s Eiger BioPharmaceuticals EIGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-117
Closed -$2K – 10159
2023
Q2
$2K Sell
117
-40
-25% -$1.23K ﹤0.01% 8522
2023
Q1
$4K Sell
157
-30
-16% -$1.4K ﹤0.01% 8243
2022
Q4
$6K Buy
187
+150
+405% +$18K ﹤0.01% 8001
2022
Q3
$8K Sell
37
-76
-67% -$18.7K ﹤0.01% 8469
2022
Q2
$21K Sell
113
-1,297
-92% -$261K ﹤0.01% 7577
2022
Q1
$351K Buy
1,410
+1,390
+6,950% +$220K ﹤0.01% 4323
2021
Q4
$3K Sell
20
-1,107
-98% -$214K ﹤0.01% 9905
2021
Q3
$294K Hold
1,127
– – ﹤0.01% 4936
2021
Q2
$287K Buy
1,127
+1,114
+8,569% +$278K ﹤0.01% 5055
2021
Q1
$346K Buy
13
+8
+160% +$2.52K ﹤0.01% 3952
2020
Q4
$200K Buy
+5
New +$1.43K ﹤0.01% 4604
2020
Q3
– Hold
0
– – – 7241
2020
Q1
– Hold
0
– -$7K – 8452
2019
Q4
– Hold
0
– – – 6587
2015
Q2
– Hold
0
– -$94K – 6000
2015
Q1
– Hold
0
– – – 1135

Other funds holding EIGR

Simplex Trading's EIGR Position: Q1 2024 in Review

Simplex Trading sold out of Eiger BioPharmaceuticals (EIGR) in Q1 2024, closing a stake of 437 shares — an estimated $2K sold.

Simplex Trading first reported a position in EIGR in Q1 2015 and held it in 13 quarters. The position peaked at $532K in Q1 2022. 24 funds tracked by Wall St. Rank hold EIGR as of Q1 2024.

  • Simplex Trading reported no remaining Eiger BioPharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Simplex Trading sold 437 Eiger BioPharmaceuticals shares in Q1 2024, an estimated $2K.
  • Simplex Trading first reported a position in Eiger BioPharmaceuticals in Q1 2015 and held it in 13 quarters.
  • Simplex Trading's Eiger BioPharmaceuticals position peaked at $532K in Q1 2022.
  • 24 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals as of Q1 2024.

Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.